ALUR Earnings Prediction
The chart below shows how ALUR performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ALUR sees a +12.22% change in stock price 10 days leading up to the earnings, and a -8.80% change 10 days following the report. On the earnings day itself, the stock moves by +0.78%. This data can give you a slight idea of what to expect for the next quarter's release.
ALUR Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
5.37M
-70.51%
-54.39%
Gross Margin
57.97%
-24.47%
-24.15%
Operating Margin
-229.94%
60.01%
189.49%
Net Margin
-167.77%
41.16%
813.28%
EPS
-3.51
-550.00%
6920.00%
No Data Available
ALUR Earnings Analysis
Allurion Technologies, Inc. Corporation (ALUR.N) Earnings Conference Call
Positive
AI Product Revenue Surge: 1. Revenue Growth in AI Products: Allurion's AI product revenues grew more than 80% year-over-year, indicating strong demand and market acceptance.
Middle East Procedure Growth: 2. Increased Procedure Volumes in the Middle East: Procedure volumes in the Middle East grew by 20% compared to last year, showcasing a recovery and growing market for Allurion's offerings.
Sales and Marketing Cost Cuts: 3. Cost Reduction in Sales and Marketing: Sales and marketing expenses decreased by 63% to $5.2 million, driven by increased operational efficiency and reduced DTC marketing, which supports profitability efforts.
Effective Weight Loss Results: 4. Positive Clinical Data: Recent studies showed that patients using the Allurion Program lost an average of 12.2% of their total body weight in just four months, reinforcing the effectiveness of the product.
Solid Financial Foundation: 5. Strong Cash Position: As of September 30, 2024, Allurion had cash and cash equivalents of $28.7 million, providing a solid financial foundation for future growth initiatives.
Negative
Revenue Decline Analysis: 1. Significant Revenue Decline: Q3 2024 revenue was $5.4 million, a drastic drop from $18.2 million in Q3 2023, primarily due to product recalls and market headwinds.
Gross Profit Decline: 2. Gross Profit Margin Erosion: Gross profit for Q3 2024 fell to 58%, down from 77% in the same quarter last year, impacted by lower production volumes and product recalls.
Operating Losses Decline: 3. Increased Operating Losses: Loss from operations decreased to $12.3 million in Q3 2024, but this was still a significant loss compared to $26.2 million in Q3 2023, indicating ongoing financial struggles.
Flat Revenue Outlook: 4. Flat Revenue Guidance for 2024: The company expects 2024 revenue to be flat compared to 2023, with a projected range of $30 million to $35 million, reflecting continued challenges in growth.
Cost Management Restructuring: 5. Headcount Reduction: The company has reduced its global headcount by approximately half as part of a restructuring plan aimed at cutting operating expenses by 50% in 2025, indicating severe cost management issues.
ALUR FAQs
How does ALUR typically perform around its earnings report dates?
Is Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
ALUR Earning Call Sentiment
Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
ALUR.N
-1.08%Positive
The earnings call presents a mixed picture. The strong cost reduction initiatives and a strategic shift in commercial strategy are positive, but significant revenue decline and gross profit drop due to macroeconomic factors and a product recall are concerning. The Q&A reveals optimism about the FDA approval and France market recovery, but lacks specific guidance, creating uncertainty. Overall, the sentiment is neutral as positives are balanced by negatives, and the lack of market cap data makes it difficult to predict a stronger reaction.